RxE2

11/26/2025

We sure have a lot to be thankful for this year! Happy Thanksgiving everyone!

11/25/2025

Clinical trials are the backbone of modern medicine, serving as the essential gateway through which new treatments must pass to ensure they are safe and effective. These trials are critical for researchers applying to the FDA for commercial approval.

Yet, the universal challenge in clinical research today is finding participants who qualify and will commit to the entire trial period, which leads to high dropout rates.

We sat down with clinical trial expert and licensed pharmacist Austin Tull to peel back the curtain. Tull, who previously oversaw a sizable clinical trial site with about 100 active studies, explains that high dropout rates are often a result of patients being brought into impersonal clinical trial sites without any previous relationship.

The innovative solution lies in expanding the involvement of community pharmacies.

Key Insights from our Q&A:

💡 Trust and Convenience are Paramount: Community pharmacies already have an established, trusted relationship with their customer base, which is paramount for successful patient retention.

💡 Boosting Retention: Because community pharmacies offer close proximity and are highly trusted healthcare professionals, they can be the difference between a completed trial participant and a patient lost to follow-up.

💡 Trial Fundamentals: Austin Tull demystified critical concepts like the gold standard double-blind placebo-controlled study and the four phases of investigation (Phase one tests safety, Phase two evaluates how well the drug works, Phase three confirms effectiveness on a larger scale, and Phase four is post-marketing surveillance).

RxE2 is revolutionizing this landscape by partnering with community pharmacies and providing cutting-edge technology for patient recruitment, dispensing, counseling, and operational services. This approach promises a future where clinical research is more accessible, efficient, and ultimately more successful.

Read the full conversation on our blog 👇

Introduction Clinical trials are the backbone of modern medicine, serving as the essential gateway through which new treatments must pass to ensure they are safe and effective for widespread public use. Yet, the process often seems mysterious, complex, and highly institutionalized. We sat down with....

11/18/2025

The future of clinical research hinges on community engagement, and pharmacists hold a powerful, unique position to drive this change. Their accessibility, trusted relationships, and frequent patient interactions are solving major barriers in clinical research.

📍 The High-Value "Trust Unit": While doctors and nurses are highly trusted, pharmacists combine moderate-to-high trust levels with significantly higher visit frequency (patients visit 4 to 6 times yearly). This combination creates a large "trust unit" or "Trust & Loyalty Scale" score (around 8 out of 10) that multiplies their influence over patient decisions.

📍 Solving Recruitment and Retention: Because patients already trust their pharmacists and interact with them frequently, their involvement in community-based trials increases willingness to participate and improves patient adherence and retention. Pharmacists are able to address concerns, explain protocols, and provide ongoing support.

📍 Driving Diversity and Decentralization: Community pharmacies, embedded in neighborhoods, are perfectly placed to reach populations often excluded from traditional trials, including rural, elderly, and minority groups. This decentralized model, using community pharmacies as main hubs and satellites, accelerates enrollment and makes trials more patient-friendly.

This shift leverages the pharmacist's clinical expertise and trusted patient relationships to improve trial quality, expand patient diversity, and accelerate medical innovation.

RxE2 is actively revolutionizing how clinical trials are conducted by utilizing community pharmacists, supercharged by technology for recruitment, dispensing, counseling, and operational services.

This is more than just dispensing; it’s about positioning community pharmacies as vital partners in the pursuit of real-world evidence and better patient outcomes.

Read more here: https://rxe2.com/pharmacists-trust-factor-the-key-to-unlocking-community-based-clinical-trials/

Pharmacists hold a unique and powerful position in healthcare, not only as medication experts but also as some of the most trusted professionals that patients encounter regularly. Trust is an essential element in healthcare because it influences how patients follow treatments, share information, and...

11/11/2025

🙌 Unleashing the UN-stoppable Power of Pharmacy: Major Takeaways from the RxE2 Un-Conference!

Forget standard industry seminars. We just wrapped the inaugural RxE2 un-conference—the first of its kind for pharmacists in clinical research—and the collaborative energy and insights were truly UN-precedented!

Held during American Pharmacists Month, this event adopted an uncommon format: it was participant-driven, meaning attendees created the agenda and fostered open discussion and sharing of ideas.

The central theme was clear: Community pharmacists can radically impact clinical research, enhance patient access, and, critically, unlock additional, unconventional revenue streams for their pharmacies.

📍 Key Insights into UN-questionable Trust:

*️⃣ Ethical Pillars: Dr. Donald Miller (North Dakota State University School of Pharmacy Professor Emeritus) laid the ethical foundation, stressing that a clinical trial is the most ethical way of finding out the benefits and risks of any intervention. He even noted that using a placebo is entirely ethical if there is “true doubt” about a new drug's safety and efficacy.

*️⃣ Unrivaled Credibility: Marc Ost (Eric’s RX Shoppe co-owner/CEO) emphasized the immense value of the community pharmacy's unquestionable credibility and the "direct relationship" they hold with patients for referrals.

*️⃣ The Unmatched Trust Unit: Gerald E. Finken (RxE2 CEO) quantified this relationship, noting that pharmacists interact with patients up to 32 times a year. This frequency creates an unmatched opportunity for building and maintaining the trust needed to solve long-standing industry problems.

Finken also championed the vision of the Clinical Trial Research Pharmacist (CTRP®) services, a concept recognizing pharmacists who receive specialized, unflinching training in the nuances of clinical research.

A huge thanks to all speakers and attendees, including Pharmacy Network Manager Teresa Gerbig, PharmD, for making this inaugural event an UN-forgettable success.

See what we did there? 😉

If you missed the event you can read a detailed summary and watch the recording here: https://rxe2.com/unlocking-community-based-trials-major-takeaways-from-the-inaugural-rxe2-un-conference

We are delighted to share the insights and collaborative energy from the first of its kind un-conference for Pharmacists in clinical research, hosted by RxE2. Held on October 24th, 1 pm ET, this landmark event occurred during American Pharmacists Month, emphasizing the profession's pivotal role in a...

10/31/2025

Tired of high site burden and patient drop-off?

The solution is decentralized research. By utilizing community pharmacies as accessible trial sites, complete with private counseling areas, we increase efficiency and decrease the logistical challenges faced by participants. This is how we move toward patient-focused development.

Happy American Pharmacists Month!
Download our white paper, "The Evolving Role of the Community Pharmacist: An Opportunity to Bring the Study to the Patient," and join the move to more efficient Community-Based Trials. Click here for the paper: https://rxe2.com/role-of-community-pharmacist-white-paper/

hashtag

10/28/2025

As American Pharmacists Month draws to a close, RxE2 recognizes the vital and evolving role pharmacists play in healthcare and clinical advancement. To cap off our campaign, we sat down with Teresa Gerbig, PharmD, Pharmacy Network Manager at RxE2, to discuss her personal journey, the unique position of pharmacists in clinical research, and how technology is shaping the future of patient care.

As an accessible healthcare professional, the community pharmacist is in a unique position to influence clinical research. Teresa highlights that pharmacists often know their patients on a very personal level.

This personal connection establishes pharmacists as a deeply trusted member of the health care team. This high level of trust is critical when discussing participation in clinical trials. Teresa holds herself to a high ethical standard, stating, "I would never recommend something to a patient that I wouldn’t suggest to my mother, father, or any other important person in my life".

Because of this inherent trust, when pharmacists introduce patients to opportunities that could potentially improve their healthcare outcomes, the patient gives it serious consideration. This high level of patient engagement results in quality patients for clinical trials.
Read the full article here: https://rxe2.com/apha-teresa

Introduction As American Pharmacists Month draws to a close, RxE2 recognizes the vital and evolving role pharmacists play in healthcare and clinical advancement. To cap off our campaign, we sat down with Teresa Gerbig, PharmD, Pharmacy Network Manager at RxE2, to discuss her personal journey, the un...

10/24/2025

We are live now! The very first unconference for pharmacists in clinical trials. Our first speaker is Dr. Donald Miller, Prof. Emeritus in the North Dakota State University school of pharmacy.

If you are a pharmacist interested in clinical research, join us now: https://us02web.zoom.us/j/82686363191?pwd=3JjLGEGjQYsczBndI5iaXXwyv7aku8.1

10/21/2025

Meeting new FDA requirements for diversity in clinical trials requires new approaches. Community-Based Trials are the solution! Pharmacists and their staff, often bi- or multilingual, are perfectly positioned for community outreach, ensuring trials are representative and effective.
Honor American Pharmacists Month by supporting their expanding role in research.

Download the white paper, "The Evolving Role of the Community Pharmacist: An Opportunity to Bring the Study to the Patient," to see how we tackle DEI goals. Click to download: https://rxe2.com/role-of-community-pharmacist-white-paper/

10/13/2025

Pharmacists are consistently rated among the most trusted healthcare providers, and that trust is the key to trial success! This American Pharmacists Month, we celebrate the unique relationship pharmacists build, which is crucial for achieving better metrics in Community-Based Trials.
Learn how strong pharmacist-patient relationships boost recruitment and adherence.

Download the white paper: "The Evolving Role of the Community Pharmacist: An Opportunity to Bring the Study to the Patient". Click here: https://rxe2.com/role-of-community-pharmacist-white-paper/

10/13/2025

On Women Pharmacists Day (October 12th), and continuing our American Pharmacists Month features, we salute the dedication and incredible expertise of the Woman Pharmacists of RxE2!

We were honored to speak with Shavon Singh, PharmD, Director of Pharmacy Services at RxE2, who shared her insights derived from a broad career journey spanning hospital settings, community dispensing, nuclear pharmacy, industry, and pharmacovigilance.

Key Insights from Shavon:

📍 Enhancing Clinical Trials, Everywhere: Community pharmacists are playing an increasingly crucial role in making clinical trials successful. They enhance the process by connecting potential patients to opportunities, providing patients with access to new or alternative treatment options.

📍 The Essential Role of Pharmacists: Pharmacists are truly an essential part of the web of healthcare. Their role extends far beyond dispensing, contributing in vital ways such as conducting health screenings, giving immunizations, advising on the safe use of medications, and collaborating with other healthcare professionals. These contributions are essential for achieving optimal patient outcomes.

📍 The Power of Technology: Technology is key in connecting healthcare providers together for the ultimate benefit of the patient. This connectivity allows for enhanced communication and better assessment measures, leading to improved patient treatment. Looking ahead, technology will further enhance patient care by optimizing treatment from all aspects.

RxE2 salutes Shavon Singh, PharmD, and all dedicated women pharmacists who are driving innovation and ensuring optimal patient care throughout the year.

Read more in the link below.

Introduction Continuing with our American Pharmacists Month features, we are especially excited to celebrate Women Pharmacists Day on October 12th by highlighting the incredible expertise and dedication of the Woman Pharmacists of RxE2. Today, we sat down with Shavon Singh, PharmD, Director of Pharm...

10/07/2025

Happy American Pharmacists Month! Recognizing the power of community care, we explore how integrating pharmacists brings research closer to the patient. Want faster, smarter Community-Based Trials? The secret is leveraging the local pharmacy.

Download our white paper, "The Evolving Role of the Community Pharmacist: An Opportunity to Bring the Study to the Patient," to learn how we are driving efficiency and patient engagement in clinical research. Click here to download: https://rxe2.com/role-of-community-pharmacist-white-paper/

10/02/2025

NCPA2025 is coming up and we'll be there! Our Pharmacy Network Manager, Teresa Gerbig, PharmD will be representing RxE2 at the CPESN booths 1326-1327 on Sunday, October 19th (12:00pm–4:30pm) and Monday, October 20th (12:30pm–5:00pm).

You can also find our CEO Gerald E. Finken at the convention!

Stop by to learn how RxE2 is driving community pharmacy forward. More info about the event here: https://ncpa.org/annual-convention